SCHEDULE 13G/A: Patient Capital Management Discloses 5.83% Stake in Canada Goose Holdings, Patient Opportunity Trust Reduces Position Below 5%

Patient Capital Management, LLC and its managed entity, Patient Opportunity Trust, have filed an amended Schedule 13G disclosing their beneficial ownership in Canada Goose Holdings Inc., with Patient Opportunity Trust reducing its stake from 6.33% to 4.15%.

Summary

• Patient Capital Management, LLC, an investment adviser, reported beneficial ownership of 2,671,192 shares of Canada Goose Holdings Inc. common stock, representing 5.83% of the class.
• Patient Opportunity Trust, a series of Advisor Managed Portfolios and an investment company managed by Patient Capital Management, LLC, reported beneficial ownership of 1,903,482 shares, representing 4.15% of the class as of March 31, 2025.
• This filing is an Amendment No. 2 to a previous Schedule 13G.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• Patient Opportunity Trust's beneficial ownership decreased from 2,900,000 shares (6.33%) as of December 31, 2024, to 1,903,842 shares (4.15%) as of March 31, 2025.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain positive or negative sentiment regarding the issuer's performance or outlook. The reduction in stake by one entity is a factual change in ownership, not an explicit positive or negative for the company itself.

Future Outlook

NA

Management Comments

• Milton Dodge, Chief Compliance Officer of Patient Capital Management, LLC, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• Russell B. Simon, President of Patient Opportunity Trust, also certified the same regarding the acquisition and holding of securities.

Industry Context

This filing is a standard disclosure of beneficial ownership by an institutional investor and does not provide specific industry context for Canada Goose Holdings Inc. beyond indicating an investment in the consumer discretionary sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor's stake, and a reduction in one of its managed funds' positions below the 5% threshold, can influence market perception and potentially share price.

Key Dates

Keywords

Canada Goose Holdings Inc., Patient Capital Management LLC, Patient Opportunity Trust, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Investment Company, SEC Filing, Ownership Disclosure